No photo of Dan Xu

View Scopus Profile

Dan Xu

  • 259 Citations
20112021

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

PhD, The Ohio State University

… → 2011

Fingerprint Dive into the research topics where Dan Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

A novel therapy for scleroderma using biodegradable nanoparticles

Miller, S. D., Varga, J. & Xu, D.

Scleroderma Foundation

9/1/18 → 8/31/21

Project: Research project

    • Regulation of the Profibrotic Mechanisms of MACRO+ Myeloid Cells in Scleroderma

    Bhattacharyya, S., Miller, S. D., Varga, J. & Xu, D.

    National Institute of Arthritis and Musculoskeletal and Skin Diseases

    6/1/18 → 5/31/20

    Project: Research project

    • Innate and Adaptive Immunity in Epileptogenesis of Childhood Epilepsy

    Miller, S. D. & Xu, D.

    Epilepsy Foundation of America

    2/1/13 → 1/31/14

    Project: Research project

    • Innate and Adaptive Immunity in Epileptogenesis

    Miller, S. D. & Xu, D.

    Ann & Robert H. Lurie Children's Hospital of Chicago, National Institute of Neurological Disorders and Stroke

    7/15/11 → 8/31/15

    Project: Research project

    Research Output

    • 259 Citations
    • 7 Article
    • 2 Review article
    • 1 Comment/debate

    Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy

    Xu, D., Robinson, A. P., Ishii, T., Duncan, DA. S., Alden, T. D., Goings, G. E., Ifergan, I., Podojil, J. R., Penaloza-MacMaster, P., Kearney, J. A., Swanson, G. T., Miller, S. D. & Koh, S., Apr 1 2018, In : Journal of Experimental Medicine. 215, 4, p. 1169-1186 18 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations

    Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells

    Prasad, S., Neef, T., Xu, D., Podojil, J. R., Getts, D. R., Shea, L. D. & Miller, S. D., May 2018, In : Journal of Autoimmunity. 89, p. 112-124 13 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations

    Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice

    Jeong, S. J., Cooper, J. G., Ifergan, I., McGuire, T. L., Xu, D., Hunter, Z., Sharma, S., McCarthy, D., Miller, S. D. & Kessler, J. A., Dec 2017, In : Neurobiology of Disease. 108, p. 73-82 10 p.

    Research output: Contribution to journal › Article

    • 15 Scopus citations

    Targeting the GM-CSF receptor for the treatment of CNS autoimmunity

    Ifergan, I., Davidson, T. S., Kebir, H., Xu, D., Palacios-Macapagal, D., Cann, J., Rodgers, J. M., Hunter, Z. N., Pittet, C. L., Beddow, S., Jones, C. A., Prat, A., Sleeman, M. A. & Miller, S. D., Nov 2017, In : Journal of Autoimmunity. 84, p. 1-11 11 p.

    Research output: Contribution to journal › Article

    • 20 Scopus citations

    A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers

    Kim, I., Mlsna, L. M., Yoon, S., Le, B., Yu, S., Xu, D. & Koh, S., Dec 1 2015, In : Brain and Behavior. 5, 12, p. 1-4 4 p.

    Research output: Contribution to journal › Article

    • 22 Scopus citations